Guidance for Industry and FDA Staff
By Whole Grain Label Statements. 2006
1,019 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/bb967105206b485978e17c3e8a92ff0a726a1bec
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Philip H. S. Torr
- Sergey Levine
- Yoshua Bengio
- Atilim Gunes Baydin
- Anca Dragan
- Bernt Schiele
- Tegan Maharaj
- Trevor Darrell
Citations in the corpus
- Managing extreme AI risks amid rapid progress (2023, background): “Doing so, they would follow best practices for risk management from industries such as aviation 85 , medical devices 86 , and defense software 87 , where companies make safety cases 88–92 : structured arguments with falsifiable claims supported by evidence, which identify potential hazards,…”
- Biology-inspired Microphysiological System Approaches to Solve the Prediction Dilemma of Substance Testing (2016, unknown): “Three DDT qualification programs are currently being implemented in the FDA Center for Drug Development and Research: (1) biomarkers; (2) clinical outcome assessments; and (3) animal models (FDA, 2014b).”